Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Hopper

Showing results (521-530 of 894) with videos related to

Pageof 90
Sort By:
Plos One|February 10, 2018
Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populationsHarsh Sheth, Emma Northwood, Cornelia M Ulrich, et al.
The American Journal of Surgical Pathology|April 19, 2012
Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinicsChristophe Rosty, Daniel D Buchanan, Michael D Walsh, et al.
Ebiomedicine|March 30, 2025
Intratumoural pks<sup>+</sup>Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndromeYen Lin Chu, Peter Georgeson, Mark Clendenning, et al.
International Journal of Cancer|April 22, 2016
Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort studyHarindra Jayasekara, Jeanette C Reece, Daniel D Buchanan, et al.
Cancer Research|February 21, 2006
Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significanceGeorgia Chenevix-Trench, Sue Healey, Sunil Lakhani, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 2, 2016
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal CancerAung Ko Win, Mark A Jenkins, James G Dowty, et al.
Genes, Chromosomes & Cancer|March 29, 2014
Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registryDominique Scherer, Lisel M Koepl, Elizabeth M Poole, et al.
Gut|January 8, 2021
Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriersPeter Georgeson, Bernard J Pope, Christophe Rosty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2006
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Antonis C Antoniou, Livia Kelemen, et al.
British Journal of Haematology|August 14, 2009
A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosisClare C Constantine, Greg J Anderson, Chris D Vulpe, et al.
Pageof 90

Showing results (521-530 of 894) with videos related to

Sort By:
Pageof 90
Plos One|February 10, 2018
Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populationsHarsh Sheth, Emma Northwood, Cornelia M Ulrich, et al.
The American Journal of Surgical Pathology|April 19, 2012
Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinicsChristophe Rosty, Daniel D Buchanan, Michael D Walsh, et al.
Ebiomedicine|March 30, 2025
Intratumoural pks<sup>+</sup>Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndromeYen Lin Chu, Peter Georgeson, Mark Clendenning, et al.
International Journal of Cancer|April 22, 2016
Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort studyHarindra Jayasekara, Jeanette C Reece, Daniel D Buchanan, et al.
Cancer Research|February 21, 2006
Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significanceGeorgia Chenevix-Trench, Sue Healey, Sunil Lakhani, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 2, 2016
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal CancerAung Ko Win, Mark A Jenkins, James G Dowty, et al.
Genes, Chromosomes & Cancer|March 29, 2014
Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registryDominique Scherer, Lisel M Koepl, Elizabeth M Poole, et al.
Gut|January 8, 2021
Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriersPeter Georgeson, Bernard J Pope, Christophe Rosty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2006
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Antonis C Antoniou, Livia Kelemen, et al.
British Journal of Haematology|August 14, 2009
A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosisClare C Constantine, Greg J Anderson, Chris D Vulpe, et al.
Pageof 90